Michael Smith was a British-born Canadian biochemist and businessman. He shared the 1993 Nobel Prize in Chemistry with Kary Mullis for his work in developing site-directed mutagenesis. Following a PhD in 1956 from the University of Manchester, he undertook postdoctoral research with Har Gobind Khorana at the British Columbia Research Council in Vancouver, British Columbia, Canada. Subsequently, Smith worked at the Fisheries Research Board of Canada Laboratory in Vancouver before being appointed a professor of biochemistry in the UBC Faculty of Medicine in 1966. Smith's career included roles as the founding director of the UBC Biotechnology Laboratory and the founding scientific leader of the Protein Engineering Network of Centres of Excellence (PENCE). In 1996 he was named Peter Wall Distinguished Professor of Biotechnology. Subsequently, he became the founding director of the Genome Sequencing Centre at the BC Cancer Research Centre.
Marco A. Marra is a Distinguished Scientist and Director of Canada's Michael Smith Genome Sciences Centre at the BC Cancer Research Centre and Professor of Medical Genetics at the University of British Columbia (UBC). He also serves as UBC Canada Research Chair in Genome Science for the Canadian Institutes of Health Research and is an inductee in the Canadian Medical Hall of Fame. Marra has been instrumental in bringing genome science to Canada by demonstrating the pivotal role that genomics can play in human health and disease research.
Sunnybrook Health Sciences Centre (SHSC), commonly known as Sunnybrook Hospital or simply Sunnybrook, is an academic health science centre located in Toronto, Ontario, Canada. It is the largest trauma centre in Canada and one of two trauma centres in Toronto, the other being St. Michael's Hospital. Sunnybrook is a teaching hospital fully affiliated with the University of Toronto. The hospital is home to Canada's largest veterans centre, in the Kilgour Wing and the George Hees, which cares for World War II and Korean War veterans.
Vancouver General Hospital is a medical facility located in Vancouver, British Columbia. It is the largest facility in the Vancouver Hospital and Health Sciences Centre (VHHSC) group of medical facilities. VGH is Canada's third largest hospital by bed count, after Hamilton General Hospital, and Foothills Medical Centre.
The Kolling Institute is located in the grounds of the Royal North Shore Hospital in St Leonards, Sydney Australia. The institute, founded in 1920, is the oldest medical research institute in New South Wales.
B.C. Women's Hospital & Health Centre, an agency of the Provincial Health Services Authority (PHSA), is a Canadian hospital located in Vancouver, British Columbia, Canada, specializing in women's health programs. It is the only facility in Western Canada dedicated to the health of women, newborns and families, and is the largest maternity hospital in the country. It is a teaching hospital and major provincial health care resource, and is a key component in women's health research.
BC Cancer is part of the Provincial Health Services Authority in British Columbia, Canada.
The Cambridge Biomedical Campus is the largest centre of medical research and health science in Europe. The site is located at the southern end of Hills Road in Cambridge, England.
British Columbia Children's Hospital is a medical facility located in Vancouver, British Columbia, and is an agency of the Provincial Health Services Authority. It specializes in health care for patients from birth to 16 years of age. It is also a teaching and research facility for children's medicine. The hospital includes the Sunny Hill Health Centre, which provides specialized services to children and youth with developmental disabilities aged birth to 18 years.
Allen Charles Edward Eaves is the founding Director of the Terry Fox Laboratory for Hematology/Oncology Research, which over a 25-year period (1981–2006) he grew into an internationally recognized centre for the study of leukemia and stem cell research. His own research on chronic myelogenous leukemia (CML) has led the way to a new understanding of the disease. As Head of Hematology at the British Columbia Cancer Agency and the University of British Columbia for 18 years (1985–2003) he engineered the building of one of the first and largest bone marrow transplant programs in Canada. In recognition of his research accomplishments and leadership in moving basic science discoveries in stem cell biology into the clinic, he was elected President of the International Society of Cellular Therapy (1995–1997), Treasurer of the Foundation for the Accreditation of Cellular Therapy (1995–2002) and President of the American Society of Blood and Marrow Transplantation (1999–2000). In 2003 he was awarded the prestigious R. M. Taylor Medal by the Canadian Cancer Society and the National Cancer Institute of Canada. In 2016 he was awarded the Order of British Columbia as well as named Ernst and Young's Entrepreneur Of The Year™ Pacific.
Royal Columbian Hospital (RCH) is the oldest hospital in British Columbia and one of the busiest in the Fraser Health Authority. It is located in New Westminster overlooking the Fraser River and is the only hospital in the Lower Mainland that is immediately adjacent to a Skytrain station (Sapperton).
The Ontario Institute for Cancer Research (OICR) is a not-for-profit organization based in Toronto, Ontario, Canada that focuses on the prevention, early detection, diagnosis and treatment of cancer. OICR intends to make Ontario more effective in knowledge transfer and commercialization while maximizing the health and economic benefits of research findings for the people of Ontario. OICR was launched in 2005 by the Government of Ontario, which provides funding through the Ministry of Colleges and Universities. The Institute employs more than 300 people at its research hub at the MaRS Centre in downtown Toronto and funds more than 1,900 scientific staff at hospital-based research institutes and universities around the province. In 2018 it was the highest funder of cancer research in Canada.
Michael R. Hayden, is a Killam Professor of Medical Genetics at the University of British Columbia, the highest honour UBC can confer on any faculty member. Only four such awards have ever been conferred in the Faculty of Medicine. Dr. Hayden is also Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).
Aubrey Tingle is professor emeritus in the Department of Pediatrics at the University of British Columbia (UBC) and chair of the board of directors at the Maternal, Infant, Child and Youth Research Network. In March 2001, Tingle was appointed the first president and CEO of The Michael Smith Foundation for Health Research (MSFHR).
The Edinburgh Cancer Research Centre (ECRC), also known as the Cancer Research UK Edinburgh Centre and the University of Edinburgh Cancer Research Centre, is a center for basic, translational and clinical cancer research located in Edinburgh, Scotland. ECRC constitutes a part of the Institute of Genetics & Molecular Medicine (IGMM) and is positioned in direct proximity of the Western General Hospital, where most of its clinical activities take place.
Abbotsford Regional Hospital and Cancer Centre (ARHCC) is a 300-bed Canadian health care facility in the City of Abbotsford, British Columbia that houses the acute care Abbotsford Regional Hospital (ARH) operated by Fraser Health and the regional cancer facility operated by the BC Cancer Agency.
Professor Colleen Nelson is a scientist in prostate cancer research. Professor Nelson founded and directs the Australian Prostate Cancer Research Centre - Queensland (APCRC-Q). The Centre, based at the Translational Research Institute and the Princess Alexandra Hospital, spans the spectrum of discovery of new therapeutic targets and their preclinical and clinical development. Professor Nelson is also Chair of Prostate Cancer Research at Queensland University of Technology (QUT).
The Victorian Comprehensive Cancer Centre (VCCC) is a multi-site, multi-disciplinary specialist cancer hospital and research centre located in Melbourne, Victoria, Australia. The VCCC comprises an alliance between The University of Melbourne, the Peter MacCallum Cancer Centre, Melbourne Health, the Walter and Eliza Hall Institute of Medical Research, the Royal Women's Hospital, the Royal Children's Hospital, Western Health, St Vincent's Hospital, Melbourne, Austin Health, and the Murdoch Childrens Research Institute.
The BC Centre for Disease Control is the public health arm for British Columbia's Provincial Health Services Authority.
Gina Suzanne Ogilvie is a Canadian global and public health physician. She is a Tier 1 Canada Research Chair in Global Control of HPV Related Diseases and Cancer, and Professor at the University of British Columbia in the School of Population and Public Health, Faculty of Medicine.
